Defining the best protection strategies and providing you with answers adapted to your specific needs
You are an academic research player, or a French or foreign company, and work in the field of:
- immunotherapy: naked or drug-conjugated antibodies, immunomodulation (e.g. cytokines, immune checkpoint inhibitors), prophylactic or therapeutic vaccines, adoptive cell transfer therapies (e.g. CAR-T), etc.)
- immunoanalysis, particularly as applied to diagnosis: tests involving antibodies, flow cytometry, immunohistochemistry, immunofluorescence, functional tests, etc.
TCR, CDR, Fc, Fab, ADC, ADCC, CDC, FACS, ELISA, ELISPOT… These acronyms hold no secrets for our experts at Regimbeau, who will help you and advise you on how to effectively protect all your inventions, even the most complex ones!
Patentability of antibodies and diagnostic or therapeutic methods, SPCs, biosimilars, specific regulatory requirements… Regimbeau’s teams keep abreast of the latest developments relating to the protection of these inventions, not only in France but also in Europe and internationally.